AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
3min chapter
Daratumumab as maintenance therapy for transplant-eligible patients with NDMM: What have we learned from GRIFFIN and CASSIOPEIA trials?
Multiple Myeloma Hub
Treatment Efficacy Comparison in Newly Diagnosed Multiple Myeloma Patients
Exploring the impact of incorporating DEROTUMAMAB in the treatment regimen for multiple myeloma patients, comparing outcomes with and without maintenance therapy, based on the Griffin and Cassiopeia trials.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode